Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 45,987,000 | 27,428,000 | 23,850,000 | 24,197,700 | 22,636,000 |
| Cost of Goods | 18,396,000 | 9,019,000 | 5,583,000 | 6,140,700 | 6,001,100 |
| Gross Profit | 27,591,000 | 18,409,000 | 18,267,000 | 18,057,000 | 16,634,900 |
| Operating Expenses | 24,236,000 | 14,388,000 | 12,182,000 | 12,440,200 | 12,948,400 |
| Operating Income | 3,355,000 | 4,021,000 | 6,085,000 | 5,617,500 | 3,686,600 |
| Other Income | -1,702,000 | 11,269,000 | 3,846,000 | -2,125,400 | 2,534,800 |
| Pre-tax Income | 1,653,000 | 15,290,000 | 9,931,000 | 3,492,100 | 6,221,400 |
| Income Tax | 671,000 | 2,268,000 | 1,999,000 | 95,300 | 1,787,600 |
| Net Income Continuous | 982,000 | 13,022,000 | 7,932,000 | 3,396,800 | 4,433,800 |
| Minority Interests | 121,000 | 123,000 | 124,000 | 121,400 | N/A |
| Net Income | $861,000 | $12,899,000 | $7,808,000 | $3,275,400 | $4,433,800 |
| EPS Basic Total Ops | 0.28 | 5.67 | 3.65 | 1.51 | 2.04 |
| EPS Basic Continuous Ops | 0.32 | 5.74 | 3.71 | 1.57 | 2.04 |
| EPS Diluted Total Ops | 0.28 | 5.65 | 3.63 | 1.49 | 2.03 |
| EPS Diluted Continuous Ops | 0.31 | 5.73 | 3.70 | 1.55 | 2.03 |
| EBITDA(a) | $10,736,000 | $6,597,000 | $7,716,000 | $7,605,700 | $5,955,000 |